Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240638 Organic Compounds and their uses
09/23/2010US20100240637 Inhibitors of the Interaction Between MDM2 and P53
09/23/2010US20100240636 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
09/23/2010US20100240635 Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
09/23/2010US20100240634 Fluorene Compound and Pharmaceutical Use Thereof
09/23/2010US20100240633 Cancer treatment methods
09/23/2010US20100240632 Drug for improving hyperglycemia
09/23/2010US20100240631 Pharmaceutical composition for the sublingual administration of progesterone, and method for its preparation
09/23/2010US20100240630 Compounds and therapeutic uses thereof
09/23/2010US20100240629 Polymorphs of fluticasone furoate and processes for preparation thereof
09/23/2010US20100240628 Skin treatments
09/23/2010US20100240627 Composition and methods relating to glucocorticoid receptor-alpha and peroxisome proliferator-activated receptors
09/23/2010US20100240626 Antiemetic-oral contraceptive combination
09/23/2010US20100240625 Ophthalmic Formulations of Cetirizine and Methods of Use
09/23/2010US20100240624 Ophthalmic Formulations of Ketotifen and Methods of Use
09/23/2010US20100240623 8-oxoadenine derivatives acting as modulators of tlr7
09/23/2010US20100240622 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/23/2010US20100240621 Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
09/23/2010US20100240620 3-Cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases
09/23/2010US20100240619 Fungicidal mixtures
09/23/2010US20100240618 Substituted piperazines
09/23/2010US20100240617 Bicyclic sphingosine 1-phosphate analogs
09/23/2010US20100240616 Novel lipid compounds
09/23/2010US20100240615 Nitric oxide donors
09/23/2010US20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
09/23/2010US20100240613 Pyrimidine compound and medical use thereof
09/23/2010US20100240612 Prenylated Bisphosphonates as Anti-tuberculosis Agents
09/23/2010US20100240611 Methods for preparing dpp-iv inhibitor compounds
09/23/2010US20100240610 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
09/23/2010US20100240609 Phthalocyanine salt formulations
09/23/2010US20100240608 particle stabilised oil-in-water emulsion
09/23/2010US20100240607 Dextrin-containing composition for preventing surgical adhesions
09/23/2010US20100240606 Associations of xanthogenates and cyclodextrins, and their use
09/23/2010US20100240605 Novel immunotherapy strategy
09/23/2010US20100240604 Protected nucleotide analogs
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100240602 Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds
09/23/2010US20100240601 Coordination Complexes, Pharmaceutical Solutions Comprising Coordination Complexes, and Methods of Treating Patients
09/23/2010US20100240600 Anti-Norovirus Agent and Composition Containing the Same
09/23/2010US20100240599 Antioxidant constituents
09/23/2010US20100240588 Compound for use in the treatment of peripheral neuropathies
09/23/2010US20100240581 Selective proteasome inhibitors for treating diabetes
09/23/2010US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof
09/23/2010US20100240578 Anti-h5n1 influenza activity of the antiviral protein cyanovirin
09/23/2010US20100239696 Flaxseed lignan complex, methods of using amd compositions thereof
09/23/2010US20100239694 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
09/23/2010US20100239693 Cannabinoid-containing plant extracts as neuroprotective agents
09/23/2010US20100239692 Methods of treatment for hemolysis
09/23/2010US20100239690 Composition for oral cavity and skin
09/23/2010US20100239689 Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
09/23/2010US20100239688 Combination of anti-angiogenic substance and anti-tumor platinum complex
09/23/2010US20100239686 Method For Making Nanolipidic Particles
09/23/2010US20100239685 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same
09/23/2010US20100239681 Controlled Release Particulates Containing Water-Insoluble Drug
09/23/2010US20100239678 Ionically functionalized nanodiamonds
09/23/2010US20100239674 Pharmaceutical composition for the treatment and prevention of diseases involving impotence
09/23/2010US20100239673 Blood compatible nanomaterials and methods of making and using the same
09/23/2010US20100239672 Layer silicate nanocomposites of polymer hydrogels and their use in tissue expanders
09/23/2010US20100239670 Topical Composition Method for Treating Urinary Stress Incontinence
09/23/2010US20100239669 Combinations of statins and anti-obesity agent
09/23/2010US20100239668 Segmented pharmaceutical dosage forms
09/23/2010US20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding
09/23/2010US20100239665 Pharmaceutical nimodipine compositions
09/23/2010US20100239664 Forms of rifaximin and uses thereof
09/23/2010US20100239663 Composition for foodstuff for binding acetaldehyde
09/23/2010US20100239661 Pharmaceutical compositions of ursodiol
09/23/2010US20100239660 Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions
09/23/2010US20100239659 Self-assembling amphiphilic polymers as anti-cancer agents
09/23/2010US20100239657 Composite for liver-specific delivery and release of therapeutic nucleic acids or drugs
09/23/2010US20100239656 Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
09/23/2010US20100239655 Taurine-based compositions and therapeutic methods
09/23/2010US20100239653 Pharmaceutical preparations and methods for inhibiting tumors
09/23/2010US20100239650 Isothiazolin biodelivery systems
09/23/2010US20100239649 Tumor Suppressor Factor
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239645 Methods and Compositions for Wound Healing
09/23/2010US20100239641 Warming vapor pad
09/23/2010US20100239639 Medicated patch
09/23/2010US20100239638 Chewable soft capsule having improved ingestion property and method for producing same
09/23/2010US20100239636 Methods and Devices for Delivering Therapeutic Agents to Target Vessels
09/23/2010US20100239634 Compositions and methods for promoting bone formation
09/23/2010US20100239632 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
09/23/2010US20100239631 Thiopyrimidine-based compounds and uses thereof
09/23/2010US20100239615 Compositions and methods for the therapy and diagnosis of lung cancer
09/23/2010US20100239608 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
09/23/2010US20100239603 Combinations of Botanical Extracts for Promoting Cardiovascular Health
09/23/2010US20100239599 Vaccine Peptide Combinations Against Cat Allergy
09/23/2010US20100239596 Grp78 and tumor angiogenesis
09/23/2010US20100239592 Methods of analysis and detecting molecular defects in transcobalamin i deficiency
09/23/2010US20100239587 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
09/23/2010US20100239576 Amino ester derivatives, sailts thereof and methods of use
09/23/2010US20100239572 Methods for treating and preventing gi syndrome and graft versus host disease
09/23/2010US20100239568 Diagnostics and treatments for tumors
09/23/2010US20100239566 Enigma-mdm2 interaction and uses thereof
09/23/2010US20100239565 Methods of treatment of skin ulcers
09/23/2010US20100239563 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases
09/23/2010US20100239562 Kv CHANNELS IN NEURODEGENERATION AND NEUROPROTECTION
09/23/2010US20100239558 Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases
1 ... 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 ... 7860